FIFTH AMENDMENT TO DEVELOPMENT AND COMMERCIALIZATION AGREEMENTAnd Commercialization Agreement • November 16th, 2012 • ProUroCare Medical Inc. • Surgical & medical instruments & apparatus
THIS FIFTH AMENDMENT TO DEVELOPMENT AND COMMERCIALIZATION AGREEMENT (this “Fifth Amendment”) is made as of the 27th day of October, 2012, by and between Artann Laboratories, Inc. (“Artann”), a New Jersey corporation and ProUroCare Medical Inc. (“ProUroCare”), a Nevada corporation.
